Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi AventisfiledCriticalSanofi Aventis
Priority to UY30760ApriorityCriticalpatent/UY30760A1/es
Publication of UY30760A1publicationCriticalpatent/UY30760A1/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
RESUMEN Derivados de urea y derivados de sulfamida en calidad de inhibidores de TAFIa La invencion se refiere a compuestos de formula I que son inhibidores del inhibidor de la fibronolisis activable por trombina activado. Los compuestos de la formula I son adecuados para fabricar medicamentos para la profilaxis, la prevencion secundaria y la terapia de uno o mas trastornos que están asociados con trombosis, embolismos, hipercoagulabilidad o cambios fibroticos.
UY30760A2007-12-042007-12-04Derivados de urea y derivados de sulfamida en calidad de inhibidores de tafia
UY30760A1
(es)